Published in TB and Outbreaks Week, November 1st, 1999
On July 16, 1999, Wyeth Lederle Vaccines temporarily suspended further distribution and administration of RotaShield until more data on the potential association between vaccine administration and intussusception became available. That action was taken in consultation with the U.S. Food and Drug Administration (FDA) following a recommendation from the U.S. Centers for Disease Control and Prevention (CDC) to postpone...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.